SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-23-007326
Filing Date
2023-10-17
Accepted
2023-10-17 16:48:30
Documents
2
Period of Report
2023-10-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1743
2 POA STUART DUTY duty_poa2023.txt EX-24 3110
  Complete submission text file 0001562180-23-007326.txt   6420
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services

Mailing Address 22722 29TH DR SE SUITE 100 BOTHELL WA 98021
Business Address
Duty Stuart (Reporting) CIK: 0001970274 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 231330075